Please login to the form below
Evox Therapeutics
This page shows the latest Evox Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Duchenne UK backs Evox dystrophin delivery project
Funding will drive preclinical studies on dystrophin-bearing exosomes. Oxford University spin-out Evox Therapeutics has won a £656, 000 ($858, 000) grant from a UK medical charity to test its ... Evox spun out of Oxford University in 2016 with £10m in
Latest news
-
Redmile and Google help Evox raise £35.5m for exosome pipeline
It is reported that GV contributed £10m of the total. Oxford University spin-out Evox Therapeutics has raised £35.5m (around $45m) in a second-round financing that will be used ... The Series B funding will also be used to develop the exosome delivery
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest appointments
-
Robert Freisen joins Ablynx
He succeeds Dr Antonin de Fougerolles, who left the company last year to become Evox Therapeutics’ chief executive officer. ... He has previously held roles for ProQR Therapeutics, Janssen BioTherapeutics, and MorphoSys.
-
Tony de Fougerolles joins Evox Therapeutics as CEO
Oxford, UK-based Evox Therapeutics has appointed its new chief executive officer in the form of Tony de Fougerolles. ... Dr Lundin said: “After a thorough selection process, I am incredibly pleased that Tony is joining the team as we continue to
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Account Director
-
Competitive
-
Medical Editor
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- Nucleus Global announces a trio of promotions
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Attigo (part of the Mednet Group)
Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
